RECEPTOS, INC.
Profile
Company Names
RECEPTOS, INC.
RECEPTOS, INC. (F.K.A. RECEPTOR PHARMACEUTICALS INC.)
Addresses
10835 ROAD TO THE CURE, SUITE 205, SAN DIEGO, CA 92121
10835 ROAD TO THE CUREL,, #205, SAN DIEGO, CA 92121
Phone Numbers
(858) 652-5712
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2008
State Incorporated:
DE
Total Amount Raised:
$30,480,065.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2012-02-03
$10,806,610.00
$50,000,011.00
$39,193,401.00
Equity
2
2009-11-09
$11,999,999.00
$20,024,000.00
$8,024,001.00
Equity
1
2009-05-11
$7,673,456.00
$7,673,456.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
KRISTINA
BUROW
DIRECTOR
KILIMANJARO ENERGY, INC.
| LIMERICK BIOPHARMA INC
| RECEPTOS, INC.
| TRELYS, INC.
| CENEXYS, INC.
| LYCERA CORP
| ARCH VENTURE FUND VIII, L.P.
| AGBIOME, LLC
| METACRINE, INC.
| SIENNA LABS, INC.
| SCHOLAR ROCK LLC
| UNITY BIOTECHNOLOGY, INC.
| ARCH VENTURE FUND IX, L.P.
| BORAGEN, INC.
| SIENNA BIOPHARMACEUTICALS, INC.
| SCHOLAR ROCK HOLDING CORP
| GOSSAMER BIO, INC.
| VIR BIOTECHNOLOGY, INC.
| BEAM THERAPEUTICS INC.
| VIVIDION THERAPEUTICS, INC.
| ARCH VENTURE FUND X, L.P.
| ARCH VENTURE FUND X OVERAGE, L.P.
| BOUNDLESS BIO, INC.
| ARCH VENTURE FUND XI, L.P.
| TREELINE BIOSCIENCES, INC.
| ARCH VENTURE FUND XII, L.P.
| NEUMORA THERAPEUTICS, INC.
| MIRADOR THERAPEUTICS, INC.
| AUTOBAHN THERAPEUTICS, INC.
| METSERA, INC.
DOUG
COLE
DIRECTOR
PAUL
GRAYSON
DIRECTOR
SHEILA
GUJRATHI
EXECUTIVE OFFICER
FAHEEM
HASNAIN
EXECUTIVE OFFICER, DIRECTOR
CHRYSA
MINEO
EXECUTIVE OFFICER
AMIR
NASHAT
DIRECTOR
PROMEDIOR INC
| AVILA THERAPEUTICS INC
| PERVASIS THERAPEUTICS INC
| FATE THERAPEUTICS INC
| BIND BIOSCIENCES INC
| SELECTA BIOSCIENCES INC
| POLARIS VENTURE PARTNERS VI, L.P.
| SUN CATALYTIX CORP
| RECEPTOS, INC.
| POLARIS ENTREPRENEURS- FUND VII, L.P.
| POLARIS PARTNERS VII, L.P.
| ATYR PHARMA INC
| AGBIOME, LLC
| METACRINE, INC.
| SCHOLAR ROCK LLC
| 1366 TECHNOLOGIES INC
| SOFREGEN MEDICAL INC.
| POLARIS ENTREPRENEURS- FUND VIII, L.P.
| SYROS PHARMACEUTICALS, INC.
| SCHOLAR ROCK HOLDING CORP
| CAMP4 THERAPEUTICS CORP
| MORPHIC HOLDING, LLC
| FREENOME HOLDINGS, INC.
| PRIMMUNE THERAPEUTICS, INC.
| MORPHIC HOLDING, INC.
ROBERT
NELSEN
DIRECTOR
FORGE INC
| RECEPTOS, INC. (F.K.A. RECEPTOR PHARMACEUTICALS INC.)
| AGIOS PHARMACEUTICALS INC
| KILIMANJARO ENERGY, INC.
| NEUROGESX INC
| KYTHERA BIOPHARMACEUTICALS INC
| SYROS PHARMACEUTICALS, INC.
| FATE THERAPEUTICS INC
| CENEXYS, INC.
| JUNO THERAPEUTICS, INC.
| BELLEROPHON THERAPEUTICS LLC
| FARADAY PHARMACEUTICALS, INC.
| SAPPHIRE ENERGY, INC.
| UNITY BIOTECHNOLOGY, INC.
| ARIVALE INC.
| SIENNA BIOPHARMACEUTICALS, INC.
| GOSSAMER BIO, INC.
| VIR BIOTECHNOLOGY, INC.
| BEAM THERAPEUTICS INC.
| GRAIL, INC.
| APEX NEURO HOLDINGS, INC.
| NUTCRACKER THERAPEUTICS, INC.
| SANA BIOTECHNOLOGY, INC.
| INSITRO, INC.
| NATIONAL RESILIENCE, INC.
| MEDICAL CREATIONS, INC.
| NEUMORA THERAPEUTICS, INC.
| RIPPL CARE, INC.
| SEAPORT THERAPEUTICS, INC.
ROBERT
NELSON
DIRECTOR
RECEPTOS, INC. (F.K.A. RECEPTOR PHARMACEUTICALS INC.)
| TRADEHARBOR INC
| WISCONSIN BANCSHARES, INC.
| AXION POWER INTERNATIONAL, INC.
| CALLMINER, INC.
| LB REIT LLC
| GLOBAL ONE PROMENADE CO-INVESTMENT LLC
| GLOBAL LANDS END LLC
| SIENNA LABS, INC.
| GLOBAL ONE REAL ESTATE FUND II, L.P.
| BEAM THERAPEUTICS INC.
| LYELL IMMUNOPHARMA, INC.
| GLOBAL ONE 36TH CO-INVESTMENT LLC
| EVERGREEN GARDENS, INC.
| CLRS X LLC
| FINNEY S11 1 JOINT VENTURE
| FINNEY S11 2 JOINT VENTURE
| TITUS 1 JOINT VENTURE
| MINDIMMUNE THERAPEUTICS, INC.
| NORTH TITUS 1 JOINT VENTURE
WILLIAM
RASTETTER
DIRECTOR, EXECUTIVE OFFICER
JAMES
SCHMIDT
EXECUTIVE OFFICER
RAYMOND
STEVENS
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

